$LUCY

Dabrowski Konrad sold $12K of LUCY

Dabrowski Konrad (Chief AI & Growth Officer) sold 13,627 shares of Innovative Eyewear Inc (LUCY) at an average of $0.87 ($0.69–$1.06) across 2 trades over 2026-04-02 to 2026-08-19.

Original reporting
SEC EDGAR · Dabrowski Konrad
Published Aug 24, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LUCY
Neutral
high confidence
Mentioned
$LUCY
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LUCYNeutralLow
01

Why it matters

The disclosed sale is modest and does not suggest a change in company fundamentals.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming dilution or financing events not disclosed in this filing.

Relevance 3/10Novelty 3/10Timing: filed today

Background

Form 4 filing reports insider transactions required by SEC regulations.

Company-level read

Ticker impact

$LUCYNeutralHigh confidence
Context

Chief AI & Growth Officer sold 13,627 shares for $11,874 via open-market transactions.

Expected impact

No significant impact; price may stay flat or dip slightly on short-term perception.

Evidence & confidence

The sale size is small relative to float and disclosed via Form 4, indicating routine liquidity need rather than loss of confidence.

Market effects

No broader sector impact; insider activity is isolated to Innovative Eyewear.

None

None

Counterpoint

If the insider holds significant knowledge, the sale could hint at upcoming challenges.

Key entities

  • Innovative Eyewear Inc

    Issuer of the LUCY ticker, microcap eyewear technology firm.

  • Dabrowski Konrad

    Chief AI & Growth Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.